Skip to content

Implementation of a Clinical Decision Support System in Primary Care for the Screening and Assessment of Frailty in Patients Aged 65 and Over

Implementation of a Clinical Decision Support System in Primary Care for the Screening and Assessment of Frailty in Patients Aged 65 and Over: A Real-World Prospective Cohort Study

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07570628
Acronym
FRAGICLIC
Enrollment
726
Registered
2026-05-06
Start date
2027-01-02
Completion date
2029-01-02
Last updated
2026-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Frailty at Older Adults, Geriatric Assessment, Implementation Research, Interprofessional Collaboration, Primary Care

Brief summary

This observational study aims to evaluate the real-life use of a digital tool (Fragiclic) by general practitioners (GPs) and nurses to screen and assess frailty in adults aged 65 and over. Frailty is a syndrome that increases the risk of loss of autonomy, falls, hospitalizations, or death. The tool includes simple screening questionnaires (such as SEGAm) and a comprehensive assessment (CGA - Comprehensive Geriatric Assessment) to better manage patients' health. The main question it aims to answer is: * What proportion of patients aged 65 and over will benefit from frailty screening or assessment using Fragiclic over 12 months? A secondary question is \- Does the use of Fragiclic reduce the risk of unplanned hospitalizations or death in these patients? For the secondary question, researchers will compare patients who received screening or assessment (with or without a Personalized Care Plan (PCP)) to those who did not, to determine if Fragiclic improves their health outcomes. Participants will not have additional tasks: Their GP or nurse will use Fragiclic during routine consultations. Some patients may be asked to provide information about their health or quality of life (via their healthcare provider). All data will be collected anonymously and securely

Interventions

None listed

Sponsors

CNGE Conseil
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Patients aged 65 years or older * Patient or trusted person who provided oral non-opposition after receiving full information about the protocol * Managed by the general practitioner if the patient or nurse during the study period. If patients are assessed by a nurse : Patients whose general practitioner is a participating physician in the study

Exclusion criteria

* Patients unable to express non-opposition or without a trusted person available to express non-opposition * Patients whose general practitioner (GP) is not a participating GP in the study * Patients or trusted persons who do not speak French

Design outcomes

Primary

MeasureTime frameDescription
Proportion of patients who have benefited from at least one screening or frailty assessment associated with a personalized care planFrom patient enrollment to the end of follow-up at 12+/-1 monthsThis includes the implementation of a screening and/or assessment, whether complete or incomplete (incomplete grid and/or incomplete or not performed PCP)

Secondary

MeasureTime frameDescription
Rates of all-cause mortality and unplanned hospitalizations among patients included in the studyFrom patient enrollment to the end of follow-up at 12+/-1 monthsThe rates of all-cause mortality and unplanned hospitalizations among patients included in the study, based on whether they underwent screening or assessment (complete or incomplete implementation) versus no implementation, and according to the assessment tool used within the Fragiclic site (SEGAm alone +/- PCP vs. CGA alone +/- PCP vs. SEGAm+CGA +/- PCP)
Number, percentage, and type of personalized care plans prescribed based on the tool used and the degree of PCP implementationat 3 months after prescriptionNumber, percentage, and type of personalized care plans (PPS) prescribed based on the tool used (SEGAm alone vs. EGS alone vs. SEGAm + EGS), and the degree of PPS implementation (actions implemented)
Acceptability of the use of the Fragiclic platform among healthcare professionals (HCP) who are users and non-usersat the end of patients follow-up, 12 months after enrollmentFeasibility (number of SEGAm, EGS, and PPS completed by users, completion time, patient refusals, number of users, and monthly logins) Perceived satisfaction with the use of the tool (qualitative study) Perceived usefulness of the tool (actions implemented, observed health outcomes) (qualitative study) Perceived difficulties in screening, frailty assessment, and implementing care and support actions (qualitative study)
Socio-demographic profiles of healthcare professionals (HCP) who are users and non-users (age, gender, mode of practice) and usage profiles (number of logins, SEGAm, EGS, and PPS completed, average usage duration)at the end of patients follow-up, 12 months after enrollmentSocio-demographic profiles : age, gender, mode of practice Usage profile : number of logins, SEGAm, CGA, and PCP completed, average usage duration
Number and percetange of complete implementation (patients with complete screening or assessment: complete frailty assessment grid and complete PPS)at the end of patients follow-up, 12 months after enrollmentComplete implementation = patients with complete screening or assessment: complete frailty assessment grid and complete PPS

Countries

France

Contacts

CONTACTLéon BANH, Dr
leon.banh@u-pec.fr01 60 17 65 65
CONTACTFazia chelli, Mrs
f.chelli@cnge.fr

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 14, 2026